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Abstract 
 
The construction of a complete EST-based gene 
index is an intricate task yet to be accomplished. 
GeneTide [1], the Gene Terra Incognita Discovery 
Endeavor (http://genecards.weizmann.ac.il/genetide/), 
which is the newest addition to the GeneCards [2] [3] 
suite of databases, comprehensively maps >4.5 of the 
~5.5 million human ESTs currently available at dbEST 
with either known or newly defined putative human 
genes. The association is accomplished via data 
mining genomic resources, and integrating using a 
unified scoring scheme. Groups of unassociated 
transcripts serve as a basis for defining EST-based 
Gene Candidates (EGCs). These EGCs are annotated 
with various parameters, including expression data, to 
determine their validity as possible de-novo genes. An 
immediate application of GeneTide to microarray 
annotation has increased, in a specific example, the 
number of annotated Affymetrix HGU95A-E probe sets 
by 50% in comparison to previous attempts. 
 
 
1. Introduction 
 
High throughput methods have generated a 
substantial number (>5 million) of Expressed 
Sequence Tags (ESTs) [4], which now offer the most 
extensive window to the entire human transcriptome, 
and to the genes coded within it. Unfortunately, given 
their fragmentary nature (typically 400-600 bases) and 
inaccurate information (1-3% sequencing errors) [5], 
assigning each of these ESTs to genes has been 
elusive. Previous and ongoing projects designed to 
address this problem, such as UniGene [6], DoTs [7], 
and AceView [8], employed different strategies, and 
have resulted in various  gene lists that exhibit only 
partial overlap. 
We have developed GeneTide, an automated system 
that offers association between ESTs and GeneCards 
genes, as well as elucidation of candidate genes based 
on EST clusters supported by expression data. This 
system is founded on the same concept underlying 
GeneCards: to sift, merge and integrate data retrieved 
from various external resources together with in-house 
generated experimental results. GeneTide significantly 
decreases the number of previously unassociated 
ESTs, offers a large number of new putative groups of 
transcripts as candidate genes for further research, and 
improves the quality of microarray annotation.  
 
2. Results and discussion 
 
GeneTide’s workflow consists of two stages – 
association with exsiting GeneCards genes, and 
defining new ones (Figure 1). For the first stage, EST 
clusters grouped by UniGene and DoTS, as well as 
gene associations by AceView, were retrieved. For 
each EST the gene associations via LocusLink 
identifier were recorded. This identifier was later used 
to associate each EST with a specific GeneCards gene. 
Next, genomic locations for the ESTs in question, 
which were obtained using BLAT [9], were 
downloaded from UCSC's genome browser database 
[10] and compared with data from GeneLoc [11], our 
exon-based system which integrates data from 
LocusLink and Ensembl to create a unified location for 
each gene. Genes located on the same genomic region 
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In addition, the GeneAnnot [12] system, the 
GeneCards family database which links Affymetrix 
GeneChip probe sets and GeneCards genes by aligning 
the probes sequences against full length mRNAs, was 
used to annotate ESTs with the same gene annotation 
as their associated probe sets. 
Figure 1. GeneTide workflow. Transcripts are 
either associated with known genes, used to define 
EST based GeneCards Candidates (EGCs), or 
discarded as artifacts. 
 
The various gene annotations obtained for each EST 
by the five aforementioned methods (UniGene, DoTS, 
AceView, BLAT & GeneLoc, and GeneAnnot) were 
integrated into a consensus and uniqueness based 
scoring scheme [1], which ranks the possible gene 
annotations by quality. 
  In defining de-novo genes, non-singleton sets of 
previously unassociated ESTs, which were supported 
by UniGene, DoTS and AceView as originating from 
the same gene, were defined as EST based GeneCards 
Candidates (EGCs), yielding nearly 20,000 such sets in 
GeneTide’s version 0.2. These EGCs were further 
annotated by extracting splicing site evidence, and 
validated by querying GeneNote [13] for the normal 
tissue expression of probe sets derived from the EGC’s 
underlying transcripts. The information collected for 
each EGC was used for testing the validity of its 
candidacy as a true gene. We are working on 
developing a ranking mechanism that will lead to a list 
of putative genes sorted by their validity, so that future 
experimental efforts can be directed at the most likely 
genes first. 
An additional application of GeneTide is in defining 
the gene origin of microarray probe sets. By assigning 
probe sets with the gene origin annotation given (via 
the process described above) to the transcript from 
which they were derived, we were able to increase by 
50% the number of Affymetrix HGU95A-E probe sets 
annotated in comparison to previous  attempts by 
GeneAnnot [12]  (version 0.3) . 
These results suggest that GeneTide holds the 
potential to uncover a large number of novel genes, 
and could significantly accelerate the elucidation of an 
inclusive EST-annotated compendium of human genes. 
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